Targeted drug delivery systems for bladder cancer therapy

被引:23
|
作者
Yu, Kun [1 ]
Liu, Meiping [1 ]
Dai, Hong [1 ]
Huang, Xiao [2 ]
机构
[1] Three Gorges Cent Hosp, Dept Urol Surg, Chongqing 404000, Peoples R China
[2] Tongren Univ, Sch Sports & Hlth Sci, Inst Nanomed & Biomat, Tongren 554300, Peoples R China
基金
中国国家自然科学基金;
关键词
Targeting strategy; Drug delivery system; Photodynamic therapy; Bladder cancer; INTRAVESICAL THERAPY; URINARY-BLADDER; NANOPARTICLES; CHEMOTHERAPY; DOXORUBICIN; STRATEGIES; ACID; RAT; CYTOTOXICITY; NANOCARRIERS;
D O I
10.1016/j.jddst.2020.101535
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Bladder cancer is a severe disease that threatens human health. The high recurrence rate and severe side-effects of traditional bladder cancer therapy require more efficient and higher targeting treatment. Drug delivery systems especially being endowed with the targeting property may provide a feasible means to solve such problems. Herein, we have reviewed the recent progress of the drug delivery systems aiming at bladder cancer therapy especially focusing on their targeting strategies. Additionally, we give some outlook of the design on targeting strategy for more effective anti-cancer applications.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Drug delivery systems based on CD44-targeted glycosaminoglycans for cancer therapy
    Li, Min
    Sun, Jiao
    Zhang, Wenjun
    Zhao, Yinan
    Zhang, Shufen
    Zhang, Shubiao
    CARBOHYDRATE POLYMERS, 2021, 251
  • [22] Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice?
    Fathi, Shaghayegh
    Oyelere, Adegboyega K.
    FUTURE MEDICINAL CHEMISTRY, 2016, 8 (17) : 2091 - 2112
  • [23] Functionalized-DNA nanostructures as potential targeted drug delivery systems for cancer therapy
    Kumar, Ajay
    Ahmad, Anas
    Ansari, Md Meraj
    Gowd, Vemana
    Rashid, Summya
    Chaudhary, Anis Ahmad
    Rudayni, Hassan Ahmed
    Alsalamah, Sulaiman A.
    Khan, Rehan
    SEMINARS IN CANCER BIOLOGY, 2022, 86 : 54 - 68
  • [24] Bio-inspired drug delivery systems: an emerging platform for targeted cancer therapy
    Neubi, Gella Maelys Ngandeu
    Opoku-Damoah, Yaw
    Gu, Xiaochen
    Han, Yue
    Zhou, Jianping
    Ding, Yang
    BIOMATERIALS SCIENCE, 2018, 6 (05) : 958 - 973
  • [25] Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and Imaging
    Lu, Ruei-Min
    Chen, Min-Shan
    Chang, De-Kuan
    Chiu, Chien-Yu
    Lin, Wei-Chuan
    Yan, Shin-Long
    Wang, Yi-Ping
    Kuo, Yuan-Sung
    Yeh, Chen-Yun
    Lo, Albert
    Wu, Han-Chung
    PLOS ONE, 2013, 8 (06):
  • [26] Recent advances in aptamer-based targeted drug delivery systems for cancer therapy
    Gao, Fei
    Yin, Jianhui
    Chen, Yan
    Guo, Changyong
    Hu, Honggang
    Su, Jiacan
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [27] Functionalized micellar systems for cancer targeted drug delivery
    Sutton, Damon
    Nasongkla, Norased
    Blanco, Elvin
    Gao, Jinming
    PHARMACEUTICAL RESEARCH, 2007, 24 (06) : 1029 - 1046
  • [28] Functionalized Micellar Systems for Cancer Targeted Drug Delivery
    Damon Sutton
    Norased Nasongkla
    Elvin Blanco
    Jinming Gao
    Pharmaceutical Research, 2007, 24 : 1029 - 1046
  • [29] siRNA and targeted delivery systems in breast cancer therapy
    Mirzaei, Sepideh
    Paskeh, Mahshid Deldar Abad
    Entezari, Maliheh
    Bidooki, Seyed Hesamoddin
    Ghaleh, Vahideh Javadian
    Rezaei, Shamin
    Hejazi, Elahe Sadat
    Kakavand, Amirabbas
    Behroozaghdam, Mitra
    Movafagh, Abolfazl
    Taheriazam, Afshin
    Hashemi, Mehrdad
    Samarghandian, Saeed
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (05): : 1167 - 1188
  • [30] siRNA and targeted delivery systems in breast cancer therapy
    Sepideh Mirzaei
    Mahshid Deldar Abad Paskeh
    Maliheh Entezari
    Seyed Hesamoddin Bidooki
    Vahideh Javadian Ghaleh
    Shamin rezaei
    Elahe Sadat Hejazi
    Amirabbas Kakavand
    Mitra Behroozaghdam
    Abolfazl Movafagh
    Afshin Taheriazam
    Mehrdad Hashemi
    Saeed Samarghandian
    Clinical and Translational Oncology, 2023, 25 : 1167 - 1188